Martin Steinau

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Performance of commercial reverse line blot assays for human papillomavirus genotyping
    Martin Steinau
    WHO Human Papillomavirus Laboratory Network Global Reference Laboratory, Chronic Viral Diseases Branch, Division of High Consequence Pathogens, and National Center for Emerging and Zoonotic Infectious Diseases Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 50:1539-44. 2012
  2. pmc Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery
    Martin Steinau
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Genomics 6:64. 2005
  3. pmc Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues
    Martin Steinau
    Chronic Viral Diseases Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Mol Diagn 13:377-81. 2011
  4. ncbi request reprint Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells
    Martin Steinau
    Division of Viral and Rickettsial Disease, Viral Exanthems and Herpesvirus Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, MS G 41, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 16:295-301. 2007
  5. doi request reprint Type-specific reproducibility of the Roche linear array HPV genotyping test
    Martin Steinau
    Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Virol 42:412-4. 2008
  6. doi request reprint Human papillomavirus genotypes in high-grade cervical lesions in the United States
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 206:1878-86. 2012
  7. pmc Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy
    Julia W Gargano
    Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, MS C09, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 21:111-21. 2012
  8. doi request reprint Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Lauri E Markowitz
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Infect Dis 208:385-93. 2013
  9. ncbi request reprint Prevalence of cervical and oral human papillomavirus infections among US women
    Martin Steinau
    Chronic Viral Diseases Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases
    J Infect Dis 209:1739-43. 2014
  10. doi request reprint Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction
    Julia W Gargano
    Epidemic Intelligence Service, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Low Genit Tract Dis 16:471-9. 2012

Collaborators

Detail Information

Publications26

  1. pmc Performance of commercial reverse line blot assays for human papillomavirus genotyping
    Martin Steinau
    WHO Human Papillomavirus Laboratory Network Global Reference Laboratory, Chronic Viral Diseases Branch, Division of High Consequence Pathogens, and National Center for Emerging and Zoonotic Infectious Diseases Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 50:1539-44. 2012
    ..942), respectively. Although the assays had good concordance in the clinical samples, the greater accuracy and specificity in the plasmid panel suggest that LA has an advantage for internationally comparable genotyping studies...
  2. pmc Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery
    Martin Steinau
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Genomics 6:64. 2005
    ..However, because of keratinization and terminal differentiation it is not clear that these cells have an mRNA profile representative of cervical tissue, and that the profile can distinguish the lesions targeted for early detection...
  3. pmc Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues
    Martin Steinau
    Chronic Viral Diseases Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Mol Diagn 13:377-81. 2011
    ..035). Aggressive heat treatment demonstrated an advantage over traditional xylene purification protocols, resulting in higher DNA yields and increased sensitivity for HPV testing...
  4. ncbi request reprint Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells
    Martin Steinau
    Division of Viral and Rickettsial Disease, Viral Exanthems and Herpesvirus Branch, Centers for Disease Control and Prevention, 1600 Clifton Road, MS G 41, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 16:295-301. 2007
    ....
  5. doi request reprint Type-specific reproducibility of the Roche linear array HPV genotyping test
    Martin Steinau
    Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Clin Virol 42:412-4. 2008
    ..Inter-assay comparability studies have been performed, but the robustness of type-specific results has neither been emphasized nor has the degree of intra-assay reproducibility been addressed...
  6. doi request reprint Human papillomavirus genotypes in high-grade cervical lesions in the United States
    Susan Hariri
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 206:1878-86. 2012
    ..Monitoring HPV types in CIN2+ may be used to assess HPV vaccine impact...
  7. pmc Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy
    Julia W Gargano
    Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, MS C09, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
    Cancer Epidemiol Biomarkers Prev 21:111-21. 2012
    ..Here, we assess age-group differences in HPV types and other risk factors for cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) versus CIN0-2 in women from four colposcopy clinics...
  8. doi request reprint Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010
    Lauri E Markowitz
    National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Infect Dis 208:385-93. 2013
    ..In 2010, 3-dose vaccine coverage was only 32% among 13-17 year-olds. Reduction in the prevalence of HPV types targeted by the quadrivalent vaccine (HPV-6, -11, -16, and -18) will be one of the first measures of vaccine impact...
  9. ncbi request reprint Prevalence of cervical and oral human papillomavirus infections among US women
    Martin Steinau
    Chronic Viral Diseases Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases
    J Infect Dis 209:1739-43. 2014
    ..6%, and partial agreement was detected in 37.7%. These data suggest that HPV infections at these 2 sites are not independent, although type-specific concordance is low. ..
  10. doi request reprint Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction
    Julia W Gargano
    Epidemic Intelligence Service, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Low Genit Tract Dis 16:471-9. 2012
    ..The study aimed to determine the baseline prevalence of human papillomavirus (HPV) types in invasive vulvar cancer (IVC) and vulvar intraepithelial neoplasia 3 (VIN 3) cases using data from 7 US cancer registries...
  11. doi request reprint Impact of HPV assay on observed population prevalence
    Elizabeth R Unger
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic, Infectious Diseases proposed, Chronic Viral Diseases Branch Atlanta, GA, USA
    Diagn Mol Pathol 20:101-4. 2011
    ..Studies designed to examine temporal trends in type-specific prevalence should archive residual material to permit retesting if assays change...
  12. doi request reprint Can clinical tests help monitor human papillomavirus vaccine impact?
    Elissa Meites
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
    Int J Cancer 133:1101-6. 2013
    ..Further investigation is warranted to inform type-specific HPV monitoring approaches around the world. ..
  13. pmc HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006
    Susan Hariri
    Division of STD Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 7:e34044. 2012
    ..This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens...
  14. pmc Molecular markers for early detection of cervical neoplasia
    Elizabeth R Unger
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA 30333, USA
    Dis Markers 20:103-16. 2004
  15. ncbi request reprint Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction
    Claudia Hopenhayn
    1Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY 2Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, and 3Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 4Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA 5Department of Epidemiology, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 6Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 7Florida Department of Health, Tallahassee, FL 8Michigan Department of Community Health, Lansing, MI 9Norris Comprehensive Cancer Center and Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 10University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 11Battelle Memorial Institute, Durham, NC and 12Markey Cancer Control Program, University of Kentucky, Lexington, KY
    J Low Genit Tract Dis 18:182-9. 2014
    ..Cases were diagnosed between 1994 and 2005 before the implementation of the HPV vaccines...
  16. pmc Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population
    Abdulrahman K Sinno
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland the Division of Gynecologic Oncology, Emory University, Department of Gynecology and Obstetrics, and the Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, and the Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia the University of Hawaii Cancer Center, University of Hawaii, Honolulu, Hawaii the Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, Iowa the Norris Comprehensive Cancer Center and Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California the Department of Epidemiology, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana the Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, and the Florida Department of Health, Tallahassee, Florida the Michigan Department of Community Health, Lansing, Michigan the Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, Kentucky and the Battelle Memorial Institute, Durham, North Carolina
    Obstet Gynecol 123:817-21. 2014
    ..To describe the human papillomavirus (HPV) genotype distribution in invasive vaginal cancers diagnosed before the introduction of the HPV vaccine and evaluate if survival differed by HPV status...
  17. pmc Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction
    Martin Steinau
    1Chronic Viral Diseases Branch, Centers for Disease Control and Prevention, Atlanta GA 2University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 3Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, CA 4Michigan Cancer Surveillance Program, Michigan Department of Community Health, Lansing, MI 5Department of Epidemiology, University of Kentucky, Lexington, KY 6Los Angeles Cancer Registry, Los Angeles, CA 7Florida Department of Health, Tallahassee, FL 8Louisiana State University Health Sciences Center, School of Public Health, New Orleans, LA 9Department of Epidemiology, University of Iowa, Iowa City, IA 10College of Medicine, University of Florida, Gainesville, FL 11Battelle Memorial Institute, Durham, NC and 12Epidemiology and Applied Research Branch, Centers for Disease Control and Prevention, Atlanta GA
    J Low Genit Tract Dis 17:397-403. 2013
    ..This study aimed to conduct a representative survey of human papillomavirus (HPV) prevalence and its genotype distribution in invasive anal cancer specimens in the United States...
  18. doi request reprint Differences and changes in human papillomavirus type 16 variant status in human immunodeficiency virus-positive adults are not uncommon
    Martin Steinau
    Centers for Disease Control and Prevention, National Center for Zoonotic, Vector Borne and Enteric Diseases, Chronic Viral Diseases Branch Atlanta, GA 30333, USA
    J Gen Virol 91:2068-72. 2010
    ..6%) instances (seven anal and two cervical) from eight different participants. Changes in HPV-16 variants in HIV-infected adults were seen most frequently when different anatomical sites were sampled, but were also observed over time...
  19. doi request reprint Oral sampling and human papillomavirus genotyping in HIV-infected patients
    Martin Steinau
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    J Oral Pathol Med 41:288-91. 2012
    ..Screening may be useful, but methodologies and results have varied widely in previous studies. We conducted a pilot study in an HIV-positive population to evaluate HPV detection in four different oral sample types...
  20. ncbi request reprint A real-time PCR assay for HPV52 detection and viral load quantification
    Juanita M Onyekwuluje
    Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of High Consequence Pathogens and Pathology, Chronic Viral Diseases Branch, Atlanta, GA 30333, USA
    Clin Lab 58:61-6. 2012
    ....
  21. doi request reprint RNA profiling in peripheral blood cells by fluorescent differential display PCR
    Martin Steinau
    National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Methods Mol Biol 496:211-22. 2009
    ..Besides the DD-PCR itself, methods are described for subsequent extraction, amplification, and sequencing of DNA from bands of interest to identify the corresponding genes...
  22. ncbi request reprint Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome
    Martin Steinau
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, MSG 41, Atlanta, GA 30333, USA
    J Mol Med (Berl) 82:750-5. 2004
    ..The real-time reverse-transcription PCR assays that we developed for assay of these biomarkers will facilitate high-throughput testing of these additional samples...
  23. doi request reprint Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
    Suzanne E Powell
    Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, NE MS E02, Atlanta, GA 30333, USA
    Vaccine 31:109-13. 2012
    ..This report describes vaccination status in women diagnosed with CIN2+ and examines HPV vaccine impact on HPV 16/18-related CIN2+...
  24. pmc DNA and RNA references for qRT-PCR assays in exfoliated cervical cells
    Martin Steinau
    Human Papillomavirus Program, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS G41, Atlanta, GA 30333, USA
    J Mol Diagn 8:113-8. 2006
    ..These genes also showed the highest correlation with DNA contents in the same samples. If special attention to intraepithelial lesions is appropriate, RPL4 and PGK1 are recommended as the best combination of two genes...
  25. doi request reprint Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact
    Eileen F Dunne
    Division of STD Prevention, Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
    Cancer Causes Control 24:403-7. 2013
    ..We aimed to assess feasibility of specimen collection and baseline HPV prevalence in an integrated healthcare delivery system...
  26. ncbi request reprint Aberrant mRNA processing of the maize Rp1-D rust resistance gene in wheat and barley
    Michael A Ayliffe
    CSIRO Plant Industry, Box 1600, Canberra, ACT, 2601, Australia
    Mol Plant Microbe Interact 17:853-64. 2004
    ....